by DMCBiotech | May 15, 2018 | DMC Press Releases, News
15 May 2018 – DMC (www.dmcbio.com), an early-stage biotechnology company, announced today Carolyn Fritz has joined their Board of Directors and will serve as Chairperson. DMC, which was founded in 2014, develops bio-based products using enhanced fermentation. Ms....
by DMCBiotech | Jan 9, 2018 | News
09 January 2018 – DMC (www.dmcbio.com), an early-stage biotechnology company, announced today that is has raised a first equity financing led by Capricorn Venture Partners. The company also announced the addition to its Board of Directors of Rob van der Meij,...
by DMCBiotech | Dec 31, 2016 | News
STTR Phase I: Commercialization of Synthetic Metabolic Valves Award Information Agency: National Science Foundation Branch: N/A Contract: 1549624 Agency Tracking Number: 1549624 Amount: $225,000.00 Phase: Phase I Program: STTR Solicitation Topic Code: BT Solicitation...
by DMCBiotech | Dec 23, 2016 | News
Award Abstract #1549624 STTR Phase I: Commercialization of Synthetic Metabolic Valves NSF Org: IIP Div Of Industrial Innovation & Partnersh Initial Amendment Date: December 18, 2015 Latest Amendment Date: December 23, 2016 Award Number: 1549624 Award Instrument:...
by DMCBiotech | May 16, 2016 | News
DOE Announces $10 Million for Innovative Bioenergy Research and Development The U.S. Department of Energy announced up to $10 million in funding for six projects representing innovative technologies and solutions to advance bioenergy development. These projects,...
